药理负荷剂对铷-82心肌灌注PET/CT患者运动的影响
该回顾性研究分析了90例行铷-82心肌灌注PET/CT患者的动态数据,比较腺苷、增量腺苷或瑞加德松三种负荷方案对患者运动的影响。结果显示瑞加德松组的运动评分显著低于腺苷组和增量腺苷组,而腺苷与增量腺苷之间无显著差异;瑞加德松组发生运动的中位帧数为12,腺苷两方案均为14。
要点
- 瑞加德松组运动评分显著低于腺苷组(P=.025定性,P<.001定量)和增量腺苷组(P=.014,P=.015)。
- 腺苷组与增量腺苷组之间运动评分差异无统计学意义。
- 在出现运动的患者中,腺苷组被归为非回返性运动的比例显著更高(P=.018)。
核心结论
- 负荷方案的选择对患者运动有显著影响,瑞加德松负荷患者的运动评分显著低于腺苷负荷患者。
研究设计与样本
- 回顾性分析90例行铷-82心肌灌注PET/CT患者的动态数据,腺苷组30例、增量腺苷组30例、瑞加德松组30例。
主要发现
- 瑞加德松组与腺苷组的定性和定量运动评分差异均有统计学意义(P=.025和P<.001)。
- 瑞加德松组与增量腺苷组的定性和定量运动评分差异均有统计学意义(P=.014和P=.015)。
- 腺苷组与增量腺苷组之间运动评分差异无统计学意义。
- 在出现运动的患者中,腺苷组被归为非回返性运动的比例显著高于其他组(P=.018)。
- 发生运动的中位帧数:瑞加德松组为12,腺苷组和增量腺苷组均为14。
关键数值与推荐
- 运动严重程度采用四点(0-3)量表定性评分,并采用逐帧像素位移定量评估。
- 记录运动类型(回返性或非回返性)及发生运动的帧。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient motion has been demonstrated to have a significant impact on the quality and accuracy of rubidium-82 myocardial perfusion PET/CT. This study aimed to investigate the effect on patient motion of two pharmacological stressing agents, adenosine and regadenoson. METHODS AND RESULTS: Dynamic data were retrospectively analyzed in 90 patients undergoing adenosine (n = 30), incremental adenosine (n = 30), or regadenoson (n = 30) rubidium-82 myocardial perfusion PET/CT. Severity of motion was scored qualitatively using a four-point (0-3) scale and quantitatively using frame-to-frame pixel shifts. The type of motion, returning or non-returning, and the frame in which it occurred were also recorded. There were significant differences in both the qualitative and quantitative scores comparing regadenoson to adenosine (P = .025 and P < .001) and incremental adenosine (P = .014, P = .015), respectively. The difference in scores between adenosine and incremental adenosine was not significant. Where motion was present, significantly more adenosine patients were classed as non-returning (P = .018). The median frames for motion occurring were 12 for regadenoson and 14 for both adenosine cohorts. CONCLUSIONS: The choice of stressing protocol impacts significantly on patient motion. Patients stressed with regadenoson have significantly lower motion scores than those stressed with adenosine, using local protocols. This motion is more likely to be associated with a drift of the heart away from a baseline position, coinciding with the termination of infusion.
引用
- Memmott MJ, Tonge CM, Saint KJ, et al. Impact of pharmacological stress agent on patient motion during rubidium-82 myocardial perfusion PET/CT. J Nucl Cardiol. 2017. PMID: 28054183. doi:10.1007/s12350-016-0767-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。